
Ju Fu Tang Biotech Holdings Co., Ltd
8217.HKHKSEIndustrialsEngineering & Construction
Latest quote
HK$0.102
−HK$0.005 · -4.67%
8217.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company website"As an investment holding company, Ju Fu Tang Biotech Holdings Co., Ltd primarily delivers a comprehensive range of civil engineering, decoration, and renovation services across Hong Kong. Its extensive portfolio covers infrastructure development, specifically road and drainage systems. This encompasses the building and enhancement of local roads and carriageway junctions, along with related facilities such as footpaths, planting zones, drainage networks, sewer lines, water mains, and utility relocation solutions. Additionally, the company undertakes foundational structural projects, including the erection of reinforced concrete structures for bridges and retaining walls. Furthermore, their expertise extends to site preparation, involving excavation and filling operations essential for new site development or future construction. The entity previously operated under the name WMHW Holdings Limited before rebranding as Ju Fu Tang Biotech Holdings Co., Ltd in September 2025. Established in 2015, the firm maintains its headquarters in Causeway Bay, Hong Kong."
- Industry
- Engineering & Construction
- Sector
- Industrials
- Headquarters
- HK
- CEO
- Chun Zhi Cai
- Listed since
- Apr 12, 2016
- Employees
- 23
Market position
Day range
Current HK$0.102
52-week range
Current HK$0.102
- Open
- HK$0.109
- Previous close
- HK$0.107
- Volume
- 1.09M
- 1.14× average
- Average volume
- 960.98K
- Average daily volume
- Market cap
- 30.79M HKD
- Beta
- 0.63
- Market reference 1
- 50-day average
- HK$0.1129
- -9.65% below average
- 200-day average
- HK$0.2627
- -61.18% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- 1.32×
- P/B (TTM)
- 0.61×
- P/S (TTM)
- 0.82×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 2.71%
- Operating margin
- -16.41%
- Net margin
- 62.09%
Financial health
- Debt / equity
- 0.24×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (HKD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 37.56M HKD | 36.2M HKD | 35.14M HKD | 104.6M HKD | 92.75M HKD |
| Cost of goods sold | 36.54M HKD | 35.22M HKD | 33.26M HKD | 107.48M HKD | 91.71M HKD |
| Gross profit | 1.02M HKD | 982K HKD | 1.88M HKD | −2.88M HKD | 1.04M HKD |
| Selling, general, and administrative | 7.18M HKD | 13.11M HKD | 7.57M HKD | 9.82M HKD | 10.63M HKD |
| Operating expenses | 7.18M HKD | 6.16M HKD | 18.59M HKD | 6.36M HKD | 20.52M HKD |
| Interest expense | 720K HKD | 720K HKD | 720K HKD | 721K HKD | 733K HKD |
| Depreciation and amortization | 40K HKD | 80K HKD | 80K HKD | 113K HKD | 339K HKD |
| Operating income | −6.16M HKD | −5.18M HKD | −16.71M HKD | −9.24M HKD | −19.48M HKD |
| Net income | 23.32M HKD | −5.9M HKD | −17.43M HKD | −9.96M HKD | −20.15M HKD |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 0.07
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Sep 13, 2021 | 1:4 | — | — |
Stock split | Mar 18, 2020 | 1:4 | — | — |
Effective Sep 13, 2021
1:4
Effective Mar 18, 2020
1:4
8217.HK peers
Continue in GoAI
Research 8217.HKresearch.disclaimer





